These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9467277)

  • 1. [Gynecologists warn against over-the-counter antifungal agents. Uncontrolled use can worsen vulvovaginal problems].
    Rylander E; Strand A
    Lakartidningen; 1998 Jan; 95(3):134-5. PubMed ID: 9467277
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems with over-the-counter vaginal preparations.
    Kabongo ML
    Am Fam Physician; 1993 Sep; 48(4):579. PubMed ID: 8379485
    [No Abstract]   [Full Text] [Related]  

  • 3. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physicians are losing control because of over-the-counter antifungal agents].
    Osterlund A
    Lakartidningen; 2002 Sep; 99(39):3868-70. PubMed ID: 12395538
    [No Abstract]   [Full Text] [Related]  

  • 5. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in prescribing for vulvovaginal candidiasis in the United States.
    McCaig LF; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):113-20. PubMed ID: 15386715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals.
    Mathema B; Cross E; Dun E; Park S; Bedell J; Slade B; Williams M; Riley L; Chaturvedi V; Perlin DS
    Clin Infect Dis; 2001 Sep; 33(5):E23-7. PubMed ID: 11477529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulvovaginal candidiasis.
    Marrazzo J
    BMJ; 2003 May; 326(7397):993-4. PubMed ID: 12742894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance against Candida is a current problem].
    Osterlund A; Strand A
    Lakartidningen; 1998 Oct; 95(41):4476-7. PubMed ID: 9803739
    [No Abstract]   [Full Text] [Related]  

  • 10. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Ferris DG; Nyirjesy P; Sobel JD; Soper D; Pavletic A; Litaker MS
    Obstet Gynecol; 2002 Mar; 99(3):419-25. PubMed ID: 11864668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical drugs for vaginal candidiasis.
    Med Lett Drugs Ther; 1991 Aug; 33(851):81. PubMed ID: 1865851
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic vulvovaginal candidiasis.
    Kuebrich CT
    N Engl J Med; 2004 Dec; 351(24):2554-6; author reply 2554-6. PubMed ID: 15590964
    [No Abstract]   [Full Text] [Related]  

  • 13. Itraconazole: better choice to treat recurrent vulvovaginal candidoses.
    Chattopadhyay S
    J Indian Med Assoc; 2004 Sep; 102(9):523. PubMed ID: 15887844
    [No Abstract]   [Full Text] [Related]  

  • 14. What to do with the patient with recurrent vulvovaginal candidiasis.
    Bingham JS
    Sex Transm Infect; 1999 Aug; 75(4):225-7. PubMed ID: 10615306
    [No Abstract]   [Full Text] [Related]  

  • 15. Cure and relapse with antifungal therapy.
    Odds FC
    Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):24-32. PubMed ID: 122690
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of candida infections.
    Scott E
    Practitioner; 1990 Mar; 234(1484):232, 234, 236. PubMed ID: 2371211
    [No Abstract]   [Full Text] [Related]  

  • 17. Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1-day and a 3-day regimen.
    Spacek J; Buchta V
    Mycoses; 2005 May; 48(3):165-71. PubMed ID: 15842331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent vulvovaginal candidiasis.
    MacNeill C; Carey JC
    Curr Womens Health Rep; 2001 Aug; 1(1):31-5. PubMed ID: 12112949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Easy access to antifungal agents.
    Faro S
    Infect Dis Obstet Gynecol; 1999; 7(3):125. PubMed ID: 10371468
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of topical antifungal agents in Spain].
    Alou Cervera L; Maestre Vera JR; Moreno Ubeda RM;
    Rev Esp Quimioter; 2001 Dec; 14(4):340-4. PubMed ID: 11856979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.